Clinical Trial Update: A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine [Phase 2]

View source ↗

Summary

Phase II trial assessing immunogenicity and safety of an HPV vaccine for Human Papillomavirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: Beijing Health Guard Biotechnology, Inc | Conditions: Human Papilloma Virus Infection | Phase 2 | Status: COMPLETED